The Framingham Risk Score -LSB- FRS -RSB- ) and the Cardiovascular Disease Life Expectancy Model ( CDLEM ) were used to estimate @-year risk of any vascular event at baseline , @ months ( trial conclusion ) , and @ months ( @ months after last trial visit ) .